These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11786314)

  • 1. Alzheimer's disease and the amyloid cascade hypothesis: ten years on.
    Sommer B
    Curr Opin Pharmacol; 2002 Feb; 2(1):87-92. PubMed ID: 11786314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness and challenges of transgenic mouse models in the study of Alzheimer's disease.
    Wilcock DM
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):386-94. PubMed ID: 20522016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives of pharmacotherapy in Alzheimer's disease.
    Yamada K; Ren X; Nabeshima T
    Jpn J Pharmacol; 1999 May; 80(1):9-14. PubMed ID: 10446751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
    Castello MA; Soriano S
    Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for rejecting the amyloid cascade hypothesis.
    Herrup K
    Nat Neurosci; 2015 Jun; 18(6):794-9. PubMed ID: 26007212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind.
    Ricciarelli R; Fedele E
    Curr Neuropharmacol; 2017; 15(6):926-935. PubMed ID: 28093977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.
    Karran E; Mercken M; De Strooper B
    Nat Rev Drug Discov; 2011 Aug; 10(9):698-712. PubMed ID: 21852788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse models of Alzheimer's disease: the long and filamentous road.
    Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
    Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
    Chu J; Lauretti E; Craige CP; Praticò D
    J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease-do tauists and baptists finally shake hands?
    Mudher A; Lovestone S
    Trends Neurosci; 2002 Jan; 25(1):22-6. PubMed ID: 11801334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological approaches for amyloid-beta clearance toward treatment for Alzheimer's disease.
    Solomon B
    Rejuvenation Res; 2008 Apr; 11(2):349-57. PubMed ID: 18341423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught?
    Verdile G; Fuller S; Atwood CS; Laws SM; Gandy SE; Martins RN
    Pharmacol Res; 2004 Oct; 50(4):397-409. PubMed ID: 15304237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.
    Shin J
    Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001
    [No Abstract]   [Full Text] [Related]  

  • 17. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
    Saxena U
    Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APP transgenic mouse models and their use in drug discovery to evaluate amyloid- lowering therapeutics.
    Hussain I
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):395-402. PubMed ID: 20522015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
    VanItallie TB
    Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amyloid cascade hypothesis has misled the pharmaceutical industry.
    Biochem Soc Trans; 2011 Aug; 39(4):920-3. PubMed ID: 21787324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.